Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVP-6124 in schizophrenia
NCT00968851Phase 2Completed
- Sponsor
- FORUM Pharmaceuticals
- Start
- Dec 2009
- Primary completion
- Jan 2011
- Countries
- 4
01
Overview
A Phase 2 trial of encenicline in schizophrenia, schizoaffective disorder, sponsored by FORUM Pharmaceuticals. Started Dec 2009; status: completed.
02
Drugs
encenicline
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00968851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00968851.